Diversify Wealth Management LLC grew its holdings in shares of AstraZeneca PLC (NASDAQ:AZN – Free Report) by 3.6% during the ...

Ameritas Advisory Services LLC increased its stake in shares of AstraZeneca PLC (NASDAQ:AZN – Free Report) by 25.9% during the fourth quarter, according to the company in its most recent disclosure ...

AstraZeneca still trades at a premium valuation, but several factors limit its upside potential in the next visible period. There are three negative takeaways from China. IRA could also ...

UK-based pharmaceutical giant AstraZeneca has announced plans to restructure its biopharma unit to concentrate on next-generation therapeutics. “In the Biopharmaceutical Business Unit, we are now ...

A new investigation published by The BMJ highlights fresh concerns about the PLATO clinical trial, a pivotal study that led to the global approval of the anti-platelet drug ticagrelor (marketed as ...

IT worker can continue legal battle against pharmaceutical giant after judge rules that impact of skin condition makes him a disabled person An IT worker has won a legal battle to sue AstraZeneca ...

AstraZeneca India has laid off over 125 employees in its biopharmaceutical business unit, including senior managers and sales executives. The job cuts are part of a strategic restructuring due to loss ...

In FY 2014-15, AstraZeneca Pharma Indias (APIL) key growth brands - Brilinta, Onglyza, Kombiglyze, witnessed robust growth, providing strong momentum to the companys performance throughout the year.

LONDON, Dec 24 (Reuters) - AstraZeneca (AZN.L), opens new tab has voluntarily withdrawn its marketing authorisation application with the EU's medicines regulator for its experimental precision ...

NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of securities of AstraZeneca PLC (NASDAQ ...